Richard Douglas, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 40,000 shares at $2.75 ($110K) on 2020-03-16, disclosed to the SEC on 2020-03-17.
Open-market purchase of $110k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MXCT | BUY | 2023-03-30 | $346K | — | Filing → |
| MXCT | BUY | 2021-11-23 | $445K | — | Filing → |
| ALDX | BUY | 2019-09-17 | $30K | — | Filing → |